(IBHI) iShares iBonds 2029 Term - Ratings and Ratios
Exchange: BATS • Country: USA • Currency: USD • Type: Etf • ISIN: US46436E3797 • Target Maturity
IBHI: High Yield Bonds, Corporate Bonds, Fixed-Rate Bonds
The iShares iBonds 2029 Term High Yield and Income ETF (BATS:IBHI) is designed to track the performance of a U.S. dollar-denominated, taxable index of fixed-rate, high-yield corporate bonds and investment-grade bonds rated BBB or equivalent. These bonds are scheduled to mature between January 1, 2029, and December 15, 2029, inclusive. The ETF may invest in debt securities of non-U.S. issuers if necessary to replicate the index. It is classified as a non-diversified fund, meaning it can concentrate its holdings in a smaller number of issuers.
As a target maturity ETF, IBHI is structured to gradually reduce its credit risk as it approaches its maturity date in 2029. This unique feature allows investors to manage interest rate risk more effectively compared to traditional bond funds. The funds focus on high-yield and BBB-rated bonds provides exposure to higher income potential, though it also carries higher credit risk compared to investment-grade debt.
3-Month Forecast: Based on the providedAdditional Sources for IBHI ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
IBHI ETF Overview
Market Cap in USD | 140m |
Category | Target Maturity |
TER | 0.35% |
IPO / Inception | 2022-03-08 |
IBHI ETF Ratings
Growth 5y | 47.3% |
Fundamental | - |
Dividend | 73.6% |
Rel. Strength Industry | -1.34 |
Analysts | - |
Fair Price Momentum | 23.41 USD |
Fair Price DCF | - |
IBHI Dividends
Dividend Yield 12m | 6.29% |
Yield on Cost 5y | 7.07% |
Annual Growth 5y | 10.99% |
Payout Consistency | 100.0% |
IBHI Growth Ratios
Growth Correlation 3m | 67.7% |
Growth Correlation 12m | 97.1% |
Growth Correlation 5y | 86.9% |
CAGR 5y | 4.16% |
CAGR/Max DD 5y | 0.30 |
Sharpe Ratio 12m | 2.85 |
Alpha | 1.75 |
Beta | 0.21 |
Volatility | 5.00% |
Current Volume | 47.6k |
Average Volume 20d | 60.5k |
As of March 14, 2025, the stock is trading at USD 23.15 with a total of 47,563 shares traded.
Over the past week, the price has changed by -1.36%, over one month by -1.37%, over three months by -0.26% and over the past year by +6.79%.
Partly, yes. Based on ValueRay Analyses, iShares iBonds 2029 Term (BATS:IBHI) is currently (March 2025) ok to buy, but has to be watched. It has a Growth Technical Rating of 47.33 and therefor an somewhat technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of IBHI as of March 2025 is 23.41. This means that IBHI is currently overvalued and has a potential downside of 1.12%.
iShares iBonds 2029 Term has no consensus analysts rating.
According to ValueRays Forecast Model, IBHI iShares iBonds 2029 Term will be worth about 25.3 in March 2026. The stock is currently trading at 23.15. This means that the stock has a potential upside of +9.46%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 25.3 | 9.5% |